1. Home
  2. EZRA vs PFSA Comparison

EZRA vs PFSA Comparison

Compare EZRA & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$2.52

Market Cap

2.1M

Sector

Finance

ML Signal

N/A

PFSA

Profusa Inc.

N/A

Current Price

$0.89

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EZRA
PFSA
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
1.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EZRA
PFSA
Price
$2.52
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.9M
169.4K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
85.79
N/A
EPS
N/A
N/A
Revenue
$12,430,959.00
$100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.05
52 Week High
$5.45
$4.22

Technical Indicators

Market Signals
Indicator
EZRA
PFSA
Relative Strength Index (RSI) 47.05 41.57
Support Level $2.03 $0.84
Resistance Level $4.02 $2.25
Average True Range (ATR) 0.40 0.11
MACD 0.05 -0.05
Stochastic Oscillator 20.35 30.82

Price Performance

Historical Comparison
EZRA
PFSA

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company that acquires, owns, and actively manages insurance and technology-focused businesses. The company focuses on growing by pursuing acquisition strategies initially, and focuses on wholesale and retail insurance agencies. Its primary move is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations. The Company operates as a single operating segment, the Insurance Segment, earning its revenues from insurance commissions.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: